InvestorsHub Logo
Followers 69
Posts 7614
Boards Moderated 0
Alias Born 01/10/2014

Re: F1ash post# 131095

Monday, 11/20/2017 9:17:39 AM

Monday, November 20, 2017 9:17:39 AM

Post# of 463629
So glad AVXL took their time to prepare a 2/3 trial using more advanced analysis and integration of the new FDA guidelines. Thus greatly improving the odds of a phase 3 success.

Such a smart move by a little company and wise use of available capital to improve odds of approval.

Thanks for pointing out the BIG PICTURE that medicine is tricky and it takes time to make progress.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News